Jun 11, 2019 / 09:40PM GMT
Patrick B. Donnelly - Goldman Sachs Group Inc., Research Division - Equity Analyst
We can look to get started. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have Steve MacMillan from Hologic, CEO, with us. There's 35-minute sessions, certainly open to questions. If you have any, just feel free to raise your hand. We'll try to look through the lights here.
But Steve, I think you wanted to just open with a few comments, then we can dive into Q&A.
Stephen P. MacMillan - Hologic, Inc. - Chairman, CEO & President
Sure, Patrick. First off, thanks for having us. Great to see you.
I think at the highest level, as you look at the company today, what we feel really good about is -- and I'd say it's kind of for the first time certainly in my tenure in 5.5 years, whatever, where we have our largest businesses going in a great trajectory as well as both U.S. and internationally. So said simply, we've got our Breast Health business doing well in the U.S. and internationally. We have our
Hologic Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers